Abstract
Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents, neurotoxicity is common, severe, and can be dose-limiting. As the list of newer chemotherapy agents and systemic "targeted therapies" grows, so does the number and variety of potential neurotoxicities. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.
Thieme Medical Publishers.
MeSH terms
-
Animals
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Brain Diseases / chemically induced*
-
Brain Diseases / complications
-
Brain Diseases / drug therapy
-
Humans
-
Neoplasms / complications
-
Neoplasms / drug therapy
-
Peripheral Nervous System Diseases / chemically induced*
-
Peripheral Nervous System Diseases / complications
-
Peripheral Nervous System Diseases / drug therapy
-
Spinal Cord Diseases / chemically induced*
-
Spinal Cord Diseases / complications
-
Spinal Cord Diseases / drug therapy